24
IRUS TotalDownloads
Altmetric
2018 FDA tides harvest
| File | Description | Size | Format | |
|---|---|---|---|---|
 pharmaceuticals-12-00052.pdf | Published version | 1.31 MB | Adobe PDF | View/Open |
| Title: | 2018 FDA tides harvest |
| Authors: | Al Shaer, D Al Musaimi, O Albericio, F De la Torre, BG |
| Item Type: | Journal Article |
| Abstract: | In 2018, the United States Food and Drug Administration (FDA) approved a total of 59 new drugs, three of them (5%) are TIDES (or also, -tides), two oligonucleotides and one peptide. Herein, the three TIDES approved are analyzed in terms of medical target, mode of action, chemical structure, and economics. |
| Issue Date: | 5-Apr-2019 |
| Date of Acceptance: | 3-Apr-2019 |
| URI: | http://hdl.handle.net/10044/1/88505 |
| DOI: | 10.3390/ph12020052 |
| ISSN: | 1424-8247 |
| Publisher: | MDPI AG |
| Start Page: | 1 |
| End Page: | 6 |
| Journal / Book Title: | Pharmaceuticals |
| Volume: | 12 |
| Issue: | 2 |
| Copyright Statement: | © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
| Keywords: | Science & Technology Life Sciences & Biomedicine Chemistry, Medicinal Pharmacology & Pharmacy dotatate drugs inotersen Lutathera oligonucleotides Onpattro patisiran peptides pharmaceutical market Tegsedi Lutathera Onpattro Tegsedi dotatate drugs inotersen oligonucleotides patisiran peptides pharmaceutical market Science & Technology Life Sciences & Biomedicine Chemistry, Medicinal Pharmacology & Pharmacy dotatate drugs inotersen Lutathera oligonucleotides Onpattro patisiran peptides pharmaceutical market Tegsedi 1115 Pharmacology and Pharmaceutical Sciences |
| Publication Status: | Published |
| Open Access location: | https://www.mdpi.com/1424-8247/12/2/52 |
| Article Number: | ARTN 52 |
| Online Publication Date: | 2019-04-05 |
| Appears in Collections: | Chemical Engineering |
This item is licensed under a Creative Commons License
